You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I squamous cell carcinoma of the nasopharynx

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Stage T3 Squamous Cell Carcinomas of the Scalp

Active, not recruiting
  • Squamous Cell Carcinoma
  • +2 more
    • Maastricht, Netherlands
      Ellen Oyen
    Aug 3, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Carrilizumab with albumin-binding paclitaxel
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 23, 2023

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

    Recruiting
    • Lung Squamous Cell Carcinoma
    • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
    • Yancheng, Jiangsu, China
      Yancheng Clinical College of Xuzhou Medical University
    Mar 21, 2023

    Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

    Recruiting
    • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +10 more
    • Intensity-Modulated Radiation Therapy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2022

    Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +11 more
    • KEYTRUDA®
    • (no location specified)
    Nov 17, 2023

    Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Houston, Texas
      M D Anderson Cancer Centerl
    Apr 25, 2023

    Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

    Recruiting
    • Neoadjuvent
    • +3 more
    • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
    • Xi'an, Shaanxi, China
    • +2 more
    Aug 17, 2023

    ESCC Trial (Tislelizumab combined with chemoradiotherapy)

    Not yet recruiting
    • ESCC
    • Tislelizumab combined with chemoradiotherapy
    • (no location specified)
    Sep 18, 2022

    Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

    Recruiting
    • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • +4 more
    • Cemiplimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 17, 2023

    Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

    Withdrawn
    • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
    • +6 more
    • hypofractionated radiation therapy
    • +3 more
    • New Brunswick, New Jersey
    • +1 more
    Sep 27, 2022

    Lung Cancer Trial in Indianapolis (Stereotactic Ablative Body Radiation (SABR))

    Terminated
    • Lung Cancer
    • Stereotactic Ablative Body Radiation (SABR)
    • Indianapolis, Indiana
    • +2 more
    Jul 22, 2022

    Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

    Active, not recruiting
    • Head and Neck Carcinoma of Unknown Primary
    • +19 more
    • Duarte, California
    • +18 more
    Aug 24, 2022

    Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

    Not yet recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • +4 more
    • Near Infrared Imaging
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 5, 2022

    Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Dec 20, 2022

    Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

    Not yet recruiting
    • Metastatic Penile Squamous Cell Carcinoma
    • +3 more
    • Enfortumab Vedotin
    • Phoenix, Arizona
    • +2 more
    Oct 23, 2023

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +7 more
    • La Jolla, California
      UC San Diego Moores Cancer Center
    Jul 20, 2022

    Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

    Not yet recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • NisinZ® P
    • Surgery (non-interventional, standard of care)
    • San Francisco, California
      University of California, San Francisco
    Oct 18, 2023

    Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Bagno A Ripoli, Firenze, Italy
    • +6 more
    Jul 27, 2022